Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

about

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy.Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study.

P2860

Q41718682-02A2E9CF-ED20-416D-B11B-AD3E205454DE Q55377929-F35F5396-A3A7-4280-BE2C-F2D8178C4DE7

P2860

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

Item

http://www.wikidata.org/entity/Q50229667

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@en

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@nl

type

Item

label

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@en

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@nl

prefLabel

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@en

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

@nl

P1476

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry

@en

P2093

C Timon

http://www.w3.org/2001/XMLSchema#string

J Kinsella

http://www.w3.org/2001/XMLSchema#string

J P O' Neill

http://www.w3.org/2001/XMLSchema#string

M L Healy

http://www.w3.org/2001/XMLSchema#string

N White

http://www.w3.org/2001/XMLSchema#string

S Deady

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Biomarker-based risk stratification for previously untreated medullary thyroid cancer.

Single center experience in primary surgery for medullary thyroid carcinoma.

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

Analysis and application of European genetic substructure using 300 K SNP information.

Cabozantinib in progressive medullary thyroid cancer.

Medullary thyroid cancer: analyses of survival and prognostic factors and the role of radiation therapy in local control.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis.

P2888

s11845-016-1455-1

P304

89-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11845-016-1455-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

186

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Green

P Lennon

Debby Lambert

P577

2016-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27083464

http://www.w3.org/2001/XMLSchema#string

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

about

P2860

P2860

Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698